Image: KitzD66, via Pixabay
US federal support aims to build on success of vaccine against Covid-19
The US federal government has awarded $176 million to the biotechnology company Moderna to support its efforts to develop a vaccine against pandemic influenza.
Announced on 2 July, the award from the Biomedical Advanced Research and Development Authority is for work using the mRNA technology Moderna used to develop one of the first vaccines against Covid-19.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.